Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.

scientific article

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12883-019-1339-X
P932PMC publication ID6556046
P698PubMed publication ID31176377

P50authorFriedemann PaulQ30353016
Juliane KlehmetQ56956565
P2093author name stringAndreas Meisel
Ralf Reilmann
Alexander U Brandt
Sarah Hoffmann
Matthias Dornauer
Svenja Beutner
P2860cites workPredictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational dataQ30624346
Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathiesQ33183443
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline dataQ33489152
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the PeQ34619228
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot studyQ35877852
Advances in the diagnosis, pathogenesis and treatment of CIDP.Q37918316
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment optionsQ38121471
Diagnosis and treatment of chronic acquired demyelinating polyneuropathiesQ38224784
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. JamarQ38991068
CIDP diagnostic pitfalls and perception of treatment benefitQ40730855
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.Q43708051
Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndromeQ44643471
Coordination of prehensile forces during precision grip in Huntington's disease.Q45300253
Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measuresQ45303227
Objective assessment of progression in Huntington's disease: a 3-year follow-up study.Q45303848
A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's diseaseQ45304326
Motor outcome measures in Huntington disease clinical trialsQ45304469
Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE studyQ46570822
Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.Q51201708
Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy.Q55284498
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP DatabaseQ57294928
The vigorimeter: for measurement of the strength of the hand and simulation testingQ67219007
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyQ67228612
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trialQ80454073
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practiceQ83100152
Does grip strength reflect isokinetic muscle strength in lower limbs in patients with chronic inflammatory demyelinating polyneuropathy?Q88230626
Ultrastructural mechanisms of macrophage-induced demyelination in CIDPQ93079381
P433issue1
P304page(s)118
P577publication date2019-06-08
P1433published inBMC NeurologyQ15763734
P1476titleQuantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
P478volume19